2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Bone Loss: new trials by email Literature Review of Bone Loss trials Research Report on Bone Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bone in CKD Alkali Response (BICARb Pilot Trial) Potassium Citrate Extended Release Oral Tablet, Placebo, Potassium Citrate and Citric Acid Oral Solution - Chronic Kidney Diseases, Bone Loss | Phase 2 / Phase 3 | Terminated | Albert Einstein College of Medicine | 6 | 2024-08-15 | 2026-07-28 |
| Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss zoledronic acid, placebo - Bone Loss | Phase 2 | Terminated | Thomas J. Schnitzer | 17 | 2010-03-01 | 2017-06-14 |
Bone Diseases, Metabolic (2) · Acidosis (1) · Fractures, Bone (1) · Osteoporosis (1) · Renal Insufficiency, Chronic (1) · Spinal Cord Injuries (1)
Bone Diseases (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Wounds and Injuries (2) · Acid-Base Imbalance (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nervous System Diseases (1) · Pathologic Processes (1)
Citric Acid (1) · Potassium Citrate (1) · Zoledronic Acid (1)
Albert Einstein College of Medicine (1) · Thomas J. Schnitzer (1)
United States (2)
Kimberly Reidy, MD (1) · Thomas J Schnitzer, MD, PhD (1)
2023 (1), R01DK131811 (1)